OTC CGMs, two years in: the glucose habit still has to earn its keep
Context, not news: the FDA cleared Dexcom Stelo in March 2024 as the first over-the-counter CGM for adults who do not use insulin, including non-diabetics who want diet-and-exercise feedback. Two years on, access is wide but the label is unchanged. It still tells users not to make medical decisions from the output without a clinician, and a useful two-week audit is not the same thing as a forever subscription.
Source · FDA – first OTC CGM clearance →